Investments in innovation and marketing enabled Galenica’s Verfora Swiss consumer healthcare operation to outpace the growth of the overall market in 2024.
Verfora – which is the number-one player in the Swiss OTC market – reported sales from the country’s pharmacies and drugstores up by 4
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?